Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02779725 · ClinicalTrials.gov registry record · NA
SymptomCare@Home: Deconstructing an Effective Symptom Management Intervention
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 884
- Enrollment target
NCT02779725: Completed NA study, sponsored by University of Utah.
NCT02779725 is a NA study that has completed, run by University of Utah. The registered enrollment target is 884 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02779725, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 884 participants
- Enrollment target
Study Summary
This project will determine the most important and cost effective components of SymptomCare@Home, a new approach to cancer chemotherapy symptom care that has been shown to reduce problematic symptoms through automated daily monitoring, self-management coaching, and oncology team follow-up care using decisional support for patients at home when their symptoms are most likely at their worse. Once the key parts of the intervention and its cost effectiveness are known, it can be moved into everyday cancer care.
Primary Outcome
During daily automated calls, patients provided information about common chemotherapy symptoms on a 0-10 scale.
Interventions
- BEHAVIORAL SCC
- BEHAVIORAL Nurse Practitioner
- BEHAVIORAL DSS
- BEHAVIORAL AT
- BEHAVIORAL Symptom Severity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 884 participants |
| Start Date | 2017-08-07 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
What the finished NCT02779725 record still lists
NCT02779725 is an interventional study that assigns participants to a tested intervention. The registered 884 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower).
The record links to 0 conditions, and to 5 interventions - of which SCC is the first listed.
NCT02779725 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02779725 about?
NCT02779725 is a clinical study titled "SymptomCare@Home: Deconstructing an Effective Symptom Management Intervention". This project will determine the most important and cost effective components of SymptomCare@Home, a new approach to cancer chemotherapy symptom care that has been shown to reduce problematic symptoms through automated daily monitoring, self-management coaching, and oncology team follow-up care using...
What is the current status of trial NCT02779725?
This trial is currently completed. It is a NA study. The enrollment target is 884 participants. The study started on 2017-08-07. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT02779725?
The interventions under investigation include: SCC (BEHAVIORAL), Nurse Practitioner (BEHAVIORAL), DSS (BEHAVIORAL), AT (BEHAVIORAL), Symptom Severity (BEHAVIORAL).
Who is sponsoring clinical trial NCT02779725?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02779725's enrollment target sits among peer trials
884 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07196748 · 882 participants · Phase 3
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
- NCT05525663 · 880 participants · NA
Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI